Brussels Diabetes Research Pole is focused on studying the mechanisms of dysfunction, death and regeneration of pancreatic beta cells in diabetes and the discovery of new biomarkers for beta cell imaging in diabetes:
Beta cell imaging based on novel biomarkers, specific Nanobodies, and imaging by SPECT-CT;
Identification and characterization of synthetic phytochemicals augmenting beta cell mass and preventing beta cell death in diabetes;
Beta cell death, dedifferentiation and regeneration during diabetes;
Development of iPSC cells to study monogenic forms of diabetes.